Trump Says Pfizer Is Rolling Back Drug ‘Price Hikes’
- Trump says in tweet that he spoke with CEO, HHS secretary
- FT report said Pfizer raised prices on about 100 products
U.S. President Donald Trump pauses while speaking to members of the media on July 10.
Photographer: Yuri Gripas/BloombergThis article is for subscribers only.
Pfizer Inc. agreed to delay implementation of planned price increases for certain drugs a day after President Donald Trump launched an attack on the company, saying it should be “ashamed” of the move.
Trump said on Tuesday evening that the New York-based company would be “rolling back price hikes” after he spoke with its chief executive officer, Ian Read, and his administration’s top health official.